CVS Health Corp. (CVS)

56.94
0.78 1.40
NYSE : Retail Trade
Prev Close 56.16
Open 56.07
Day Low/High 55.78 / 57.01
52 Wk Low/High 58.46 / 82.15
Volume 2.68M
Avg Volume 12.87M
Exchange NYSE
Shares Outstanding 1.30B
Market Cap 74.05B
EPS -0.60
P/E Ratio N/A
Div & Yield 2.00 (3.53%)

Latest News

Stocks Get Chilled: Cramer's 'Mad Money' Recap (Tuesday 3/19/19)

Stocks Get Chilled: Cramer's 'Mad Money' Recap (Tuesday 3/19/19)

Jim Cramer says there's a lot to like about this market, but he says we can't ignore that it's prone to trade-related woes.

Jim Cramer: The Ultimate Case for the Leap of Taste Not Faith

Jim Cramer: The Ultimate Case for the Leap of Taste Not Faith

I think sometimes the best way to parse the temperament is to go over the most obviously 'wrong' moves and address why they might not be wrong at all.

CVS Health Fights Rise In E-Cigarette Use Among Young Adults With More Than $1 Million In New Giving To Advance Tobacco-Free Policies On College Campuses

CVS Health Fights Rise In E-Cigarette Use Among Young Adults With More Than $1 Million In New Giving To Advance Tobacco-Free Policies On College Campuses

82 colleges and universities receive grants from CVS Health Foundation, American Cancer Society and Truth Initiative to help deliver a tobacco-free generation

EQUITY ALERT: Rosen Law Firm Reminds CVS Health Corporation Investors With Over $200K In Losses Of Important Deadline In Securities Class Action Lawsuit - CVS

EQUITY ALERT: Rosen Law Firm Reminds CVS Health Corporation Investors With Over $200K In Losses Of Important Deadline In Securities Class Action Lawsuit - CVS

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CVS Health Corporation (NYSE: CVS) from May 21, 2015 through February 20, 2019, inclusive (the "Class Period").

Weekly Roundup

Strong earnings boost shares in a rebound week for stocks.

Thank You for Joining Our Members-Only Call on Thursday

A full replay of the call will be available shortly and an edited transcript of the call will be posted in the coming days.

CVS Health

We think shares of CVS deserve to trade at a higher multiple.

Why Investors Should Be Wary of Multiple Expansion: Jim Cramer

Why Investors Should Be Wary of Multiple Expansion: Jim Cramer

Jim Cramer breaks down why investors should be careful about paying more for the same earnings estimate.

Video: Jim's Daily Rundown for Wednesday

Jim discusses Bernstein's initiation of CVS with an Outperform rating, Apple's March 25th event but why they need to focus on healthcare, and more!

CVS Rises Sharply on Bullish Initiation at Bernstein

CVS Rises Sharply on Bullish Initiation at Bernstein

Bernstein initiates coverage of CVS with an outperform rating.

Boeing and CVS: Two Sagas Worth Tracking, But Just One Worth Playing Right Now

Boeing and CVS: Two Sagas Worth Tracking, But Just One Worth Playing Right Now

With all the unknowns surrounding Boeing it's way too early to take a position in the aircraft maker; the same is not true with CVS.

Markets, Trade Deal, Cyber Attacks, My ZTO Play: Market Recon

Markets, Trade Deal, Cyber Attacks, My ZTO Play: Market Recon

National security is job one. Cutting a nice deal with China that benefits both sides must come second.

Jim Cramer: I'm Not Buying This Tech Multiple Expansion

Jim Cramer: I'm Not Buying This Tech Multiple Expansion

This is hope, not fact -- don't pay more for the same old thing.

UnitedHealth Group's Program Shows Why It Is an Industry Leader

We view the commitment to price reductions to be a crucial one that will allow UNH to differentiate itself as the fight for lower healthcare costs heats up.

Video: Jim's Daily Rundown for Tuesday

Jim discusses his view of yesterday's Apple upgrade, transparency around hospital bills, the insider buy activity at CVS, and answers club member questions!

Insider Buying Activity at CVS Health Is a Good Sign

We've seen the value at these levels, insiders are seeing it, and rest of the market should begin to see it too.

Healthy Gains Ahead for Beaten-Down CVS

Healthy Gains Ahead for Beaten-Down CVS

The market's reaction to the pharmacy giant's acquisition of Aetna is providing a rare opportunity to buy a quality company at a value price.

Updates on 4 Portfolio Names (Plus a Video)

When markets move higher, it is no time to be complacent, rather it is a perfect time to check in on the portfolio.

Game Plan After a Disastrous Week: Cramer's 'Mad Money' Recap (Friday 3/8/19)

Game Plan After a Disastrous Week: Cramer's 'Mad Money' Recap (Friday 3/8/19)

Friday's bad employment number could have been a lot worse.

Weekly Roundup

With China reducing its GDP forecast and Europe's central bank growing cautious, markets turned lower this week.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against CVS Health Corporation - CVS

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against CVS Health Corporation - CVS

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CVS Health Corporation (NYSE:CVS) from May 21, 2015 through February 20, 2019, inclusive (the "Class Period").

CVS Health Announces Aetna Foundation's $1 Million Grant To Northern Shenandoah Valley Substance Abuse Coalition To Fight Opioid Epidemic

CVS Health Announces Aetna Foundation's $1 Million Grant To Northern Shenandoah Valley Substance Abuse Coalition To Fight Opioid Epidemic

Grant is part of company's ongoing commitment to building healthier communities by supporting innovative approaches that address public health challenges

Exiting PayPal

We think the company's valuation has gotten full and we lack catalysts at the moment.

The 6 Stocks To Watch: Cramer's 'Mad Money' Recap (Thursday 3/7/19)

The 6 Stocks To Watch: Cramer's 'Mad Money' Recap (Thursday 3/7/19)

Jim Cramer's watching six stocks to determine when the selling will end.

Jim Cramer: Here Are 6 Stocks That Will Tell You What's Going On

Jim Cramer: Here Are 6 Stocks That Will Tell You What's Going On

Why am I not more worried about a recession? Because Fed Chair Jay Powell has our back.

Sorting the Good Stocks From the 'Crocks' in 2019's Market Rally

Sorting the Good Stocks From the 'Crocks' in 2019's Market Rally

The market rally may be a rising tide, but investors should be wary of some of the stocks it has lifted up.

CVS Health Corporation Announces Quarterly Dividend

CVS Health Corporation Announces Quarterly Dividend

WOONSOCKET, R.I.

TheStreet Quant Rating: C (Hold)